Kevin Warsh Sworn In as Federal Reserve Chair Amid Trumps Push for Lower Interest Rates Markets Anticipate Extended Pause
Cramers Morning Meeting Market Commentary Points to Potential Upside in Select Stocks
Citi Analysts Raise Bullish Outlook on Micron Technology Amid DRAM Market Momentum
Stock Market Gains on USIran Deal Hopes AutoZone Tumbles Elbit Systems Surges
European Companies Pursue Reindustrialisation Amid Declining Investment Plans and AIs Rising Role
US Stock Futures and Bond Yields Decline as Putin Updates Nuclear Doctrine
AAMI Q1 2026 Earnings Strong EPS Beat Drives Stock Rally
RCKY Q1 2026 Earnings Earnings Miss Consensus Despite Positive Market Response
Best Buy Co BBY Q1 2026 Earnings Solid EPS Beat Amid Mixed Consumer Electronics Demand
RBLX Q1 2026 Earnings EPS Beats Estimates Significantly Stock Rises on Narrower Loss
SWIM Q1 2026 Earnings Surpasses EPS Estimates with 5272 Surprise
MFA Financial Inc 8875 Senior Notes due 2029 MFAN Q1 2026 Earnings Slight EPS Miss Amid Stable Bond Performance
MoonLake Immunotherapeutics MLTX Edges Lower as Stock Tests Support Near 1728
Invesco Ltd IVZ Holds Near Support Amid Modest Decline Resistance Awaits
Radian Group Inc RDN Faces Resistance as Shares Dip 184 Testing Key Support Zone
Linde LIN Slips 12 as Defensive Positioning Wavers Key Support in Focus
Star Holdings STHO Shares Climb 174 as Momentum Builds Near Key Resistance
Washington Trust Bancorp Inc WASH Q1 2026 Earnings EPS Misses Estimates Stock Slightly Lower
Fortis Inc FTS Q1 2026 Earnings Modest EPS Miss Amid Steady Utility Performance
LOCO Q1 2026 Earnings EPS Surpasses Estimates by Over 27 Despite Revenue Uncertainty
CANF Q4 2023 Earnings EPS Surprise of 96 as Biotech Reports NarrowerThanExpected Loss
ANNX Q1 2026 Earnings EPS Beat Surprise as ClinicalStage Biotech Tightens Cost Control
MSEX Q1 2026 Earnings Earnings Miss Estimates as Operating Pressures Mount
London Stock Exchange Group Reports Income Growth Driven by Tradeweb Performance
TKC Q4 2025 Earnings EPS of 440 Reported Stock Declines Marginally
Prothena PRTA Edges Lower Near Support as Biotech Sector Faces Headwinds